Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:TG 18:1_18:1_25:1)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004167 AN006917 Targeted Lipidomic Profiling of STBD1 Knockdown in Clear Cell Renal Carcinoma Cells Renal cancer cells Human Cancer The Affiliated Cancer Hospital of Zhengzhou University LC-MS
ST003988 AN006569 Lipid and cell cycling perturbations driven by the HDAC inhibitor romidepsin render liver cancer vulnerable to RTK targeting and immunologically active Cultured cells Human Cancer CNRS LC-MS
ST003760 AN006174 Untargeted lipidomics of combination gemcitabine/paclitaxel attenuated (CombAT) PDAC cells Pancreas Human Cancer Victor Chang Cardiac Research Institute LC-MS
ST003678 AN006039 The effects of cystine limitation stress adaptation (CLSA) on lipidomics changes in pancreatic cancer cells Pancreas Human Cancer Pennsylvania State University LC-MS
ST002452 AN004007 Lipidomic analysis of human brain from frontotemporal dementia cases of with GRN and C9orf72 mutations Brain Human Dementia University of Sydney LC-MS
ST002398 AN003905 Lipidomics of Tango2 Deficient and Wildtype Zebrafish Muscle Tissue Muscle Zebrafish Myopathy University of North Carolina at Chapel Hill LC-MS
ST001725 AN002810 Lipidomics dataset of Danio rerio optic nerve regeneration model Eye tissue Zebrafish Eye disease University of Miami LC-MS
  logo